Armistice Capital, LLC United Therapeutics Corp Transaction History

Armistice Capital, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$79.39 - $115.35 $10.2 Million - $14.8 Million	-128,000 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$78.31 - $95.34 $7.99 Million - $9.72 Million	-102,000 Reduced 44.35%	128,000 $11.3 Million
Q3 2019 Nov 14, 2019	SELL	$74.85 - $85.99 $7.04 Million - $8.08 Million	-94,000 Reduced 29.01%	230,000 $18.3 Million
Q2 2019 Aug 14, 2019	BUY	$76.06 - $120.81 $24.6 Million - $39.1 Million	324,000 New	324,000 $25.3 Million
Q4 2018 Feb 14, 2019	SELL	$101.4 - $128.73 $29.6 Million - $37.6 Million	-292,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$113.81 - $129.46 $33.2 Million - $37.8 Million	292,000 New	292,000 $37.3 Million
Q2 2018 Aug 14, 2018	SELL	$101.14 - $118.31 $39.2 Million - $45.9 Million	-388,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$107.21 - $151.94 $20.2 Million - $28.6 Million	188,000 Added 94.0%	388,000 $43.6 Million
Q4 2017 Feb 14, 2018	BUY	$118.58 - $151.28 $5.93 Million - $7.56 Million	50,000 Added 33.33%	200,000 $29.6 Million
Q3 2017 Nov 14, 2017	BUY	$114.6 - $136.81 $17.2 Million - $20.5 Million	150,000	150,000 $17.6 Million

725

61M

123K

104K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $14.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.